Group 1: Company Buybacks - Longlide plans to repurchase company shares for no less than 56 million yuan [2] - Hanshuo Technology has obtained a commitment letter for a stock repurchase loan from a financial institution [2] - Prolo Pharmaceutical intends to use between 180 million to 360 million yuan to buy back company shares [2] Group 2: Company Sell-offs - Suda Co., Ltd. plans to reduce its holdings by no more than 3% [2] - Hunan Baiyin intends to reduce its holdings by no more than 1.95% [2] - Zimi Co., Ltd. plans to reduce its holdings by no more than 1% [2] - Zhongshui Fishery's third-largest shareholder has reduced its holdings by 2.5888 million shares, bringing its stake down to 5% [2] - We Online's investors plan to collectively reduce their holdings by no more than 5.94% [2] - Renmin Tongtai's controlling shareholder plans to reduce its holdings by no more than 1% [2] - Yanshiwei's fourth and fifth largest shareholders plan to reduce their holdings by no more than 1.5% and 1% respectively [2] - Langke Intelligent's shareholders plan to reduce their holdings by no more than 1.68% [2] - Yingben Co., Ltd.'s director plans to reduce his holdings by no more than 0.03% [2] - Sunshine Power has completed the implementation of share reduction plans by some directors and senior management [2] - Dipu Technology's shareholder plans to reduce his holdings by no more than 1.55% [2] - MediWest's shareholder plans to reduce his holdings by no more than 1.64% [2] - Huahai Qingke's shareholder plans to reduce his holdings by no more than 1% [2] - Liyuan Technology's shareholder plans to reduce his holdings by no more than 2.0303% [2] - New Emerging Equipment's shareholders plan to collectively reduce their holdings by no more than 3.13% [2] - Jinqiao Information's director plans to reduce his holdings by no more than 0.0675% [2] - Kanglongda's shareholder plans to reduce his holdings by no more than 3% [2]

证券日报网讯 11月19日晚间，力源科技发布公告称，截至2025年11月19日，深圳市中广核汇联二号新 能源股权投资合伙企业（有限合伙）（简称"汇联二号"）持有公司股份4，644，400股，占公司总股本 的3.1016%。因经营计划需求，汇联二号拟减持不超过3，040，000股（若计划减持期间公司有送股、 资本公积金转增股本等股份变动事项，上述股份数量做相应调整），占公司当前总股本的比例不超过 2.0303%。 （文章来源：证券日报） ...

Group 1 - Kanglongda's shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 4.83 million shares [1] - The company specializes in the research, production, and sales of special and ordinary labor protection gloves [1] Group 2 - Haizheng Pharmaceutical's subsidiary plans to collaborate with East China Institute on a biological method for synthesizing heparin, with a project contract amount not exceeding 120 million yuan [2] - The company focuses on the research, production, and sales of chemical raw materials and formulations [3] Group 3 - Tianyin Holdings received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [4] - The company is engaged in the sales of smart terminals, e-commerce, lottery, mobile resale, and mobile internet businesses [4] Group 4 - Shanghai Yashi plans to use up to 200 million yuan of temporarily idle raised funds for cash management in high-security, liquid deposit products [5] - The company specializes in supply chain logistics and execution trade [6] Group 5 - Parker New Materials intends to use 130 million yuan of idle raised funds to purchase structured deposits with expected annual yields between 0.59% and 2.9001% [7] - The company focuses on the research, production, and sales of various types of ring forgings, free forgings, and die forgings [7] Group 6 - Huayang New Materials appointed Jing Hongsheng as the new general manager [8] Group 7 - Liyuan Technology's shareholder plans to reduce holdings by up to 2.03% of the company's shares, totaling no more than 3.04 million shares [9] - The company specializes in the research, design, and integration of environmental water treatment systems and hydrogen fuel cell engine systems [9] Group 8 - Shengnuo Biopharmaceutical's subsidiary received approval for the listing application of Visepegenatide raw materials, a GLP-1 receptor agonist for treating type 2 diabetes and obesity [10][11] - The company focuses on the research, production, and sales of peptide raw materials and formulations [10] Group 9 - Puluo Pharmaceutical plans to repurchase shares worth between 180 million and 360 million yuan, with a maximum price of 23 yuan per share [12] - The company specializes in the research, production, and sales of raw material intermediates and innovative drugs [12] Group 10 - Dongfang Electric's subsidiary plans to establish a joint venture with Anhui Waneng Energy, with a registered capital of approximately 1.857 billion yuan [13] - The company is involved in the development, design, manufacturing, and sales of advanced power generation equipment [13] Group 11 - Hefei China announced that its stock will resume trading on November 20 after completing a review of abnormal trading fluctuations [14] - The company focuses on international trade and after-sales services related to in vitro diagnostic medical devices [14] Group 12 - Dafeng Industrial won a bid for the stage equipment project of the Shenzhen International Performing Arts Center, with a contract amount of 165 million yuan [15] - The company specializes in cultural sports equipment, digital art technology, and operation services [15] Group 13 - Baiyunshan's subsidiary received a drug registration certificate for An Gong Niu Huang Wan in Vietnam [16] - The company is engaged in the research, manufacturing, and sales of traditional Chinese and Western medicines [16] Group 14 - Neusoft Group received a notification to supply intelligent cockpit domain controllers for multiple models from a well-known domestic automobile manufacturer, with an estimated total amount of about 4.2 billion yuan [17] - The company focuses on providing industry solutions and software products [17] Group 15 - Huayu Pharmaceutical's product received overseas marketing approval [18] - The company specializes in the research, production, and sales of innovative and high-quality generic drugs in the oncology field [18] Group 16 - Yao Pi Glass received approval from the CSRC for its stock issuance to specific investors [19] - The company specializes in the production and sales of float glass and processed glass [19] Group 17 - Guangyu Yuan's vice president Wang Junbo resigned due to work adjustments [20] - The company focuses on the production and sales of traditional Chinese medicine products [20] Group 18 - Biyi Co. received approval from the CSRC for its stock issuance to specific investors [21] - The company specializes in the design, manufacturing, and sales of smart small household appliances [21] Group 19 - Sunshine Nuohe's application for acquiring 100% equity of Jiangsu Langyan Life Science Technology Co., Ltd. through share issuance and convertible bonds has been accepted by the Shanghai Stock Exchange [22] - The company provides comprehensive drug research and development services for domestic pharmaceutical enterprises and research institutions [22] Group 20 - Longxin General plans to increase capital in its wholly-owned subsidiary by no more than 1.65 billion yuan [23] - The company specializes in the research, production, and sales of motorcycles and engines [23] Group 21 - Jiekang Equipment received a corrective order from the Tianjin Securities Regulatory Bureau due to internal control deficiencies [24] - The company specializes in the research, production, and sales of nuclear biochemical safety equipment [24] Group 22 - Wantong Technology plans to raise no more than 920 million yuan through a private placement to supplement working capital [25] - The company focuses on information technology services for highways and ports [25] Group 23 - Dongshan Precision has submitted an application for H-share listing to the Hong Kong Stock Exchange [26] - The company specializes in the research, production, and sales of electronic circuit products and precision components [26] Group 24 - Yonghe Intelligent Control plans to publicly transfer 100% equity of its wholly-owned subsidiary Kunming Medical Oncology Hospital [27] - The company specializes in water and heating valve fittings, tumor precision radiation therapy, and photovoltaic battery businesses [27] Group 25 - Aok Shares signed a strategic cooperation framework agreement with Suzhou Qitian New Materials Co., Ltd. [28] - The company focuses on the research and production of high-end new materials derived from ethylene oxide and ethylene [28] Group 26 - Hongquan Technology's shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 299,440 shares [29] - The company specializes in the research, production, and sales of intelligent connected products and software platform development [29] Group 27 - Shilong Industrial's controlling shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 7.2 million shares [30] - The company specializes in the research, production, and sales of chemical products [30] Group 28 - Tangrenshen decided to terminate the investment in the "Dongchong Phase III Pig Breeding Base Construction Project," reallocating the remaining funds of 78.9587 million yuan to supplement working capital [31] - The company specializes in the research, production, and sales of feed, pigs, meat products, and animal health products [31] Group 29 - Gaode Infrared's actual controller plans to reduce holdings by up to 3% of the company's shares, totaling no more than 12.8 million shares [32] - The company specializes in infrared focal plane detector chips and infrared thermal imaging systems [32] Group 30 - Kangyuan Pharmaceutical's actual controller recently increased holdings by 20,000 shares [33] - The company specializes in the research, production, and sales of pharmaceuticals [33] Group 31 - Haida Group plans to repurchase shares worth between 1 billion and 1.6 billion yuan, with a maximum price of 62.00 yuan per share [34] - The company provides overall solutions for animal husbandry [34] Group 32 - Qizhong Technology's 850 million yuan convertible bonds have been approved for listing [35] - The company specializes in advanced packaging and testing of integrated circuits [35] Group 33 - Dingyang Technology launched the new SNA5000B series vector network analyzer [36] - The company specializes in the research, production, and sales of general electronic testing and measuring instruments [36] Group 34 - Airo Energy plans to distribute a cash dividend of 0.9375 yuan per share to all shareholders [37] - The company specializes in photovoltaic energy storage systems and products [37] Group 35 - Hechuan Technology's actual controller and some directors plan to reduce holdings by up to 6% of the company's shares [38] - The company specializes in the research, production, and sales of industrial automation products [38] Group 36 - China First Heavy Industries' chairman was arrested for suspected bribery [39] - The company specializes in heavy machinery manufacturing for various industries [39] Group 37 - Lianhuan Pharmaceutical plans to invest 15 million yuan in joint research with Nanjing University for anti-thrombotic small nucleic acid drugs [40] - The company specializes in the manufacturing and sales of chemical raw materials [40] Group 38 - Anxu Biotech's shareholder plans to reduce holdings by up to 0.94% of the company's shares, totaling no more than 120,000 shares [41] - The company specializes in the research, production, and sales of POCT reagents and instruments [41] Group 39 - Yaxiang Integration's shareholder reduced holdings by 130,000 shares [42] - The company specializes in providing cleanroom engineering and related services for high-tech electronic industries [42] Group 40 - Zhongwen Media plans to use up to 9.5 billion yuan of idle funds to purchase financial products [43] - The company specializes in traditional publishing and various new media businesses [43]

证券代码：688565 证券简称：力源科技 公告编号：2025-049 浙江海盐力源环保科技股份有限公司 5%以下股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法 律责任。 重要内容提示： 股东持股的基本情况 截至 2025 年 11 月 19 日，深圳市中广核汇联二号新能源股权投资合伙企业 （有限合伙）（以下简称"汇联二号"）持有浙江海盐力源环保科技股份有限公司 （以下简称"公司"）股份 4,644,400 股，占公司总股本的 3.1016%。上述股份 均为无限售流通股，来源于公司首次公开发行前取得的股份及通过公司 2021 年 度权益分派实施资本公积金转增股本取得的股份，涉及首次公开发行前取得的股 份已于 2022 年 5 月 13 日解除限售并上市流通。 减持计划的主要内容 因经营计划需求，汇联二号拟减持不超过 3,040,000 股（若计划减持期间公 司有送股、资本公积金转增股本等股份变动事项，上述股份数量做相应调整）， 占公司当前总股本的比例不超过 2.0303%。 其中，以集中竞价交易方式 ...

格隆汇11月19日丨力源科技(688565.SH)公布， 公司于2025年11月19日收到汇联二号出具的股份减持计 划告知函，因经营计划需求，汇联二号拟减持不超过304万股，占公司当前总股本的比例不超过 2.0303%。其中，以集中竞价交易方式减持股份，减持期间为自《浙江海盐力源环保科技股份有限公司 5%以下股东减持股份计划公告》披露之日起15个交易日后的3个月内（即2025年12月12日至2026年3月 11日），减持数量不超过149.73万股，占公司总股本比例不超过1.00%，且在任意连续60个自然日内通 过集中竞价减持股份的总数不超过公司总股本的1.00%；以大宗交易方式减持股份,减持期间为自《浙江 海盐力源环保科技股份有限公司5%以下股东减持股份计划公告》披露之日起3个交易日后的3个月内 （即2025年11月26日至2026年2月25日），减持数量不超过299.46万股，占公司总股本比例不超过 2.00%，且在任意连续60个自然日内，通过大宗交易减持股份的总数不超过公司总股本的2.00%。 ...

Summary of Key Points Core Viewpoint - The company Liyuan Technology announced a share reduction plan by its shareholder, Hui Lian No. 2, which currently holds 4.6444 million shares, accounting for 3.1016% of the total share capital [1] Group 1: Shareholder Reduction Plan - Hui Lian No. 2 plans to reduce its holdings by no more than 3.04 million shares, which represents a maximum of 2.0303% of the company's current total share capital [1] - The reduction will occur through two methods: a centralized bidding transaction from December 12, 2025, to March 11, 2026, for up to 1.4973 million shares, and a block trade from November 26, 2025, to February 25, 2026, for up to 2.9946 million shares [1] - In the past 12 months, Hui Lian No. 2 has already reduced its holdings by 1.7556 million shares, which is 1.1725% of the total share capital [1] Group 2: Impact on Company - The company states that this share reduction plan carries uncertainties but will not have a significant impact on its governance or operations [1]

国家知识产权局信息显示，广东力源科技股份有限公司取得一项名为"一种新能源汽车铝合金件水嘴压 装装置"的专利，授权公告号CN223531838U，申请日期为2024年12月。 专利摘要显示，本实用新型公开了一种新能源汽车铝合金件水嘴压装装置，包括压装设备，压装设备的 压装头上设置有水嘴装夹套，压装设备的压装工位上设置有治具板，治具板的两侧设置有工件夹紧机 构；压装设备的前侧设置有第一工件放置架，右侧设置有水嘴放置架，左侧设置有第二工件放置架，水 嘴放置架与压装设备之间设置有涂胶机构；水嘴放置架上设置有多个水嘴放置层，水嘴放置层上设置有 多个放置水嘴的水嘴放置位，第一工件放置架上设置有若干个第一工件放置位，第二工件放置架上设置 有若干个第二工件放置位，还包括水嘴移送机构和工件移送机构。 天眼查资料显示，广东力源科技股份有限公司，成立于2004年，位于肇庆市，是一家以从事汽车制造业 为主的企业。企业注册资本5000万人民币。通过天眼查大数据分析，广东力源科技股份有限公司共对外 投资了1家企业，参与招投标项目17次，财产线索方面有商标信息8条，专利信息78条，此外企业还拥有 行政许可71个。 声明：市场有风险，投资需 ...

Group 1 - On November 10, 2023, a total of 3,741 A-shares received financing funds for purchase, with 488 stocks having purchase amounts exceeding 100 million yuan [1] - The top three stocks by financing purchase amount were Yangguang Electric Power, Zhongji Xuchuang, and Xinyisheng, with amounts of 2.904 billion yuan, 2.436 billion yuan, and 2.413 billion yuan respectively [1] - Three stocks had financing purchase amounts accounting for over 30% of the total transaction amount, with Shisheng Intelligent, Ruilian New Materials, and Haocen Software leading at 39.87%, 37.79%, and 32.22% respectively [1] Group 2 - There were 46 stocks with net financing purchases exceeding 100 million yuan, with the top three being Tianfu Communication, Cambridge Technology, and China West Electric, which had net purchases of 440 million yuan, 424 million yuan, and 409 million yuan respectively [1]

Group 1 - The core viewpoint of the news is the initiation of large-scale clinical trials for gene-edited pig kidneys for human transplantation, marking a significant advancement in biotechnology and organ transplantation [1] - The first clinical trial was completed at NYU Langone Medical Center, approved by the FDA, aiming to evaluate the safety and efficacy of gene-edited pig kidneys for patients with end-stage kidney disease [1] - Global advancements in gene editing technology have been reported, including successful transplantation of gene-edited pig lungs in China and new treatment approaches for Down syndrome in Japan [1] Group 2 - Huazhong Securities highlights that breakthroughs in gene editing technology have significantly lowered the technical barriers for genetic modification, enabling large-scale industrial production of drugs [2] - In the A-share market, there are 22 listed companies with gene editing technology reserves, with mixed performance in stock prices; only 7 out of 22 companies saw gains on November 5 [4] - Among gene editing concept stocks, Shuanglu Pharmaceutical reported the highest net profit of 141 million yuan in the first three quarters, while Mengcao Ecological achieved a year-on-year profit increase of 48.73% [5][6] Group 3 - Eight gene editing concept stocks received attention from five or more institutions, with companies like Sturdy Medical and Huaxi Biological leading in institutional ratings [7] - Sturdy Medical announced a collaboration with Huazhong Agricultural University to establish a cotton research institute, focusing on gene editing and hybridization techniques for cotton seed improvement [7]

Core Viewpoint - The article discusses the advancements and competitive landscape in the green hydrogen equipment sector in China, highlighting the emergence of new products and technologies from various companies, as well as the evolving market dynamics and competitive strategies [13]. Product Launches and Innovations - In the first three quarters of 2025, 25 companies launched 32 new electrolysis hydrogen production equipment products, with AEM leading with 12 new products, followed by ALK with 10, and PEM with 9 [3][4]. - Notable companies involved in ALK new products include Huadian Science and Technology, BlueStar North Chemical Machinery, and SANY Hydrogen Energy, while PEM products were launched by companies like Huadian Science and Technology and Sinopec Hydrogen Energy Machinery [3][4]. - AEM products were introduced by Future Hydrogen, Jiangsu Hydrogen Port, and Hydrogen Hummingbird, among others [3][4]. Product Characteristics - The new products exhibit features such as high current density, wide power adjustment range, and cost reduction [7][8]. - For instance, Huadian Science and Technology's PEM electrolyzer has a current density of 30,000 A/m² and a hydrogen production capacity of ≥500 Nm³/h, with a direct current energy consumption of ≤4.35 kWh/Nm³ [9]. - The second-generation alkaline electrolyzer from Tianhe Hydrogen has a rated current density of 4,000 A/m² and a direct current consumption of as low as 3.898 kWh/Nm³, achieving a 30% reduction in equipment costs [8][9]. Competitive Landscape - The competitive landscape is characterized by a three-dimensional structure involving traditional enterprise transformation, central enterprise platform integration, and innovation from emerging companies [13]. - Companies are focusing on technological differentiation, high-quality products, standardized certification, and global expansion to build competitive advantages [13]. Market Trends - The market is witnessing a shift towards high-efficiency and low-cost hydrogen production technologies, with significant advancements in PEM and AEM technologies [7][11]. - The article emphasizes the importance of innovation and the need for companies to adapt to changing market demands and technological advancements to remain competitive [13].